5.81
price up icon3.75%   0.21
after-market 시간 외 거래: 5.81
loading

Kura Oncology Inc 주식(KURA)의 최신 뉴스

pulisher
Jun 18, 2025

Transcript : Kura Oncology, Inc.Special Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Kura Oncology Announces Positive Phase 1a/1b Trial Results - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (KURA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Kura Oncology rises after new early-stage trial data for leukemia therapy - MSN

Jun 17, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Invests $66,000 in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook - Investing.com Canada

Jun 13, 2025
pulisher
Jun 12, 2025

KURA's Ziftomenib Shows Promising Results in AML Clinical Trial - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Is the Options Market Predicting a Spike in Kura Oncology Stock? - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology (KURA) Shows Promising Results for AML Therapy - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology Says Ziftomenib Study Achieves Complete Remission in Acute Myeloid Leukemia - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology stock rises on leukemia drug data (KURA:NASDAQ) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Is The Options Market Predicting A Spike In Kura Oncology Stock? - Barchart.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combinatio - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Strong Results from KOMET-007 Trial of Ziftomenib in Newly Diagnosed AML Patients - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly ... - Enidnews.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Kura Oncology FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

KURA Stock Rises More Than 15% This Past Week: Here's Why - MSN

Jun 11, 2025
pulisher
Jun 10, 2025

Kura Oncology at Goldman Sachs Conference: Strategic Insights on ZIFTOMENIB - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Kura Oncology, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 11 - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Acquires New Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Kura Oncology Stockholders Approve Equity Plan Amendment - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Grants Stock Options To New Hires Under Inducement Plan - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rul - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology (KURA) Grants Stock Options to New Employees | KUR - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology (KURA) Grants Stock Options to New Employees | KURA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KURA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Expands Cancer Research Team with Strategic Stock Options for 5 Key New Hires - Stock Titan

Jun 06, 2025
pulisher
Jun 05, 2025

Kura Oncology’s (KURA) “Market Outperform” Rating Reaffirmed at JMP Securities - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Kura Oncology at Jefferies Conference: Strategic Advancements in AML By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

**citizens jmp reiterates market outperform rating on kura oncology stock** - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Sells 42,120 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Rising Leaders 2025: Kura Oncology’s Mollie Leoni On Setting Precedent, Not Following It - insights.citeline.com

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Lowers Stock Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Transcript : Kura Oncology, Inc. Presents at American Society of Clinical Oncology Annual Meeting 2025, Jun-02-2025 06 - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology Drug’s Data at ASCO Support FDA Filing Now Under Priority Review for Leukemia - MedCity News

Jun 03, 2025
pulisher
Jun 03, 2025

KURA: Optimism for Kura Oncology's Menin Inhibitor Grows with FDA Priority Review | KURA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cantor Fitzgerald reiterates overweight rating for Kura Oncology stock By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology reports positive trial results for AML treatment By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology at ASCO: Strategic Moves in AML Treatment By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 02, 2025

Kura Oncology reports positive trial results for AML treatment - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

KURA: Promising Results for Kura Oncology's AML Therapy at ASCO Meeting | KURA Stock News - GuruFocus

Jun 02, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):